We then used several cancer cell lines with different phenotypes of HLA-A2 or NY-ESO-1 as target cells to determine the specific cytotoxicity of the TCR-T cells in vitro by LDH assay (Figure 2C) and IFN-γ release by ELISPOT (Figure 2B). This evidence concerns the gene IFNG and cancer.